These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20823106)

  • 21. Patterns and co-occurrence of risk factors for hepatocellular carcinoma in four Asian American communities: a cross-sectional study.
    Stewart SL; Dang JH; Török NJ; Chen MS
    BMJ Open; 2019 Jun; 9(6):e026409. PubMed ID: 31256022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
    Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
    Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry.
    Wong RJ; Devaki P; Nguyen L; Cheung R; Nguyen MH
    Liver Transpl; 2014 May; 20(5):528-35. PubMed ID: 24415542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Beutler BD; Ulanja MB; Krishan R; Aluru V; Ndukwu ML; Hagen MM; Dupin ZD; Willyard CE; Moody AE; Boampong-Konam K; Zell SC
    Cancer Control; 2020; 27(1):1073274820956615. PubMed ID: 32951450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in Hepatocellular Carcinoma Outcomes Among Subgroups of Asians and Pacific Islanders: A SEER Database Study.
    Sempokuya T; Pan CW; Pattison RJ; Choi C; Nogimura A; Wong LL
    J Immigr Minor Health; 2023 Aug; 25(4):824-834. PubMed ID: 37004678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
    Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
    J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B virus (HBV) infection among Hmong immigrants in the San Joaquin Valley.
    Sheikh MY; Mouanoutoua M; Walvick MD; Khang L; Singh J; Stoltz S; Mills PK
    J Community Health; 2011 Feb; 36(1):42-6. PubMed ID: 20532597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.
    Pollack HJ; Kwon SC; Wang SH; Wyatt LC; Trinh-Shevrin C;
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2229-39. PubMed ID: 25368398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparities in Hepatocellular Carcinoma Incidence in California: An Update.
    Sangaramoorthy M; Yang J; DeRouen MC; Ho C; Somsouk M; Tana MM; Thompson CA; Gibbons J; Gomez SL; Shariff-Marco S
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):79-87. PubMed ID: 31719066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era.
    Devaki P; Wong RJ; Marupakula V; Nangia S; Nguyen L; Ditah IC; Ehrinpreis MN; Nguyen MH
    Cancer; 2014 Jun; 120(11):1725-32. PubMed ID: 24590359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study.
    Davila JA; El-Serag HB
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):104-10; quiz 4-5. PubMed ID: 16431312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
    Scaglione S; Adams W; Caines A; Devlin P; Mittal S; Singal AG; Parikh ND
    Dig Dis Sci; 2020 Jun; 65(6):1669-1678. PubMed ID: 31643036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
    Altekruse SF; McGlynn KA; Reichman ME
    J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation.
    Hwang JP; Hassan MM
    BMC Cancer; 2009 Feb; 9():46. PubMed ID: 19193234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
    Makarova M; Krettek A; Valkov MY; Grjibovski AM
    Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
    Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
    Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes.
    Sarfati D; Gurney J; Stanley J; Koea J
    BMC Cancer; 2014 Nov; 14():821. PubMed ID: 25380581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.